UBS Group
SRTS icon

UBS Group’s Sensus Healthcare SRTS Stock Holding History

UBS Group’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$688K Buy
172,870
+37,027
+27% +$164K ﹤0.01% 5831
2025
Q4 		$541K Buy
135,843
+10,998
+9% +$40.8K ﹤0.01% 6031
2025
Q3 		$392K Buy
124,845
+26,540
+27% +$104K ﹤0.01% 6258
2025
Q2 		$466K Buy
98,305
+12,737
+15% +$59.7K ﹤0.01% 6068
2025
Q1 		$405K Sell
85,568
-51,748
-38% -$301K ﹤0.01% 6019
2024
Q4 		$950K Buy
137,316
+74,937
+120% +$549K ﹤0.01% 5338
2024
Q3 		$362K Buy
62,379
+43,841
+236% +$266K ﹤0.01% 5454
2024
Q2 		$98.8K Buy
+18,538
New +$85.2K ﹤0.01% 6168
2023
Q2 		– Sell
-9,706
Closed -$50.6K – 9601
2023
Q1 		$50.6K Sell
9,706
-28,018
-74% -$201K ﹤0.01% 6444
2022
Q4 		$280K Sell
37,724
-45,919
-55% -$414K ﹤0.01% 5186
2022
Q3 		$1.05M Sell
83,643
-12,649
-13% -$151K ﹤0.01% 3719
2022
Q2 		$739K Buy
96,292
+25,768
+37% +$216K ﹤0.01% 3976
2022
Q1 		$714K Buy
70,524
+67,458
+2,200% +$616K ﹤0.01% 4421
2021
Q4 		$22K Buy
+3,066
New +$16.8K ﹤0.01% 7744
2021
Q3 		– Sell
-2,219
Closed -$9K – 10055
2021
Q2 		$9K Buy
2,219
+917
+70% +$3.44K ﹤0.01% 8156
2021
Q1 		$5K Sell
1,302
-2,567
-66% -$10.5K ﹤0.01% 8327
2020
Q4 		$15K Buy
3,869
+2,785
+257% +$8.49K ﹤0.01% 7177
2020
Q3 		$3K Sell
1,084
-891
-45% -$2.51K ﹤0.01% 7559
2020
Q2 		$6K Sell
1,975
-4,940
-71% -$12.9K ﹤0.01% 7315
2020
Q1 		$17K Buy
6,915
+2,540
+58% +$9.45K ﹤0.01% 6596
2019
Q4 		$15K Sell
4,375
-8,054
-65% -$36.5K ﹤0.01% 7064
2019
Q3 		$75K Sell
12,429
-5,271
-30% -$30.7K ﹤0.01% 5945
2019
Q2 		$98K Sell
17,700
-8,032
-31% -$47.1K ﹤0.01% 5389
2019
Q1 		$180K Buy
25,732
+11,332
+79% +$87.5K ﹤0.01% 4675
2018
Q4 		$107K Buy
14,400
+9,900
+220% +$62.9K ﹤0.01% 5480
2018
Q3 		$38K Sell
4,500
-1,862
-29% -$13.5K ﹤0.01% 6377
2018
Q2 		$47K Buy
6,362
+4,183
+192% +$27.3K ﹤0.01% 6015
2018
Q1 		$13K Buy
2,179
+179
+9% +$1.01K ﹤0.01% 6725
2017
Q4 		$10K Sell
2,000
-667
-25% -$3.62K ﹤0.01% 7034
2017
Q3 		$13K Sell
2,667
-6,233
-70% -$30.6K ﹤0.01% 6739
2017
Q2 		$36K Sell
8,900
-2,679
-23% -$10.8K ﹤0.01% 5887
2017
Q1 		$51K Sell
11,579
-1,299
-10% -$6.13K ﹤0.01% 5516
2016
Q4 		$67K Buy
12,878
+10,877
+544% +$63.5K ﹤0.01% 5599
2016
Q3 		$12K Buy
+2,001
New +$12.5K ﹤0.01% 6670

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

UBS Group's SRTS Position: Q1 2026 in Review

UBS Group increased its Sensus Healthcare (SRTS) stake by 27% in Q1 2026, buying an estimated $164K and bringing the position to 172,870 shares worth $688K. The position accounts for ﹤0.01% of the portfolio, ranked #5831.

UBS Group first reported a position in SRTS in Q3 2016 and has held it in 34 quarters since. The position peaked at $1.05M in Q3 2022. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • UBS Group held 172,870 shares of Sensus Healthcare worth $688K as of Q1 2026.
  • UBS Group bought 37,027 Sensus Healthcare shares in Q1 2026, an estimated $164K.
  • Sensus Healthcare made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5831 holding.
  • UBS Group first reported a position in Sensus Healthcare in Q3 2016 and has held it in 34 quarters since.
  • UBS Group's Sensus Healthcare position peaked at $1.05M in Q3 2022.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.